KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VivoSim Labs (VIVS) Gains from Investment Securities (2016 - 2023)

Historic Gains from Investment Securities for VivoSim Labs (VIVS) over the last 13 years, with Q1 2023 value amounting to -$9000.0.

  • VivoSim Labs' Gains from Investment Securities fell 10039.91% to -$9000.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $2.2 million, marking a year-over-year decrease of 234.68%. This contributed to the annual value of -$9000.0 for FY2023, which is 10039.11% down from last year.
  • Per VivoSim Labs' latest filing, its Gains from Investment Securities stood at -$9000.0 for Q1 2023, which was down 10039.91% from $2.3 million recorded in Q1 2022.
  • In the past 5 years, VivoSim Labs' Gains from Investment Securities ranged from a high of $2.3 million in Q1 2022 and a low of -$21000.0 during Q4 2020
  • For the 5-year period, VivoSim Labs' Gains from Investment Securities averaged around $206083.3, with its median value being $16000.0 (2019).
  • Per our database at Business Quant, VivoSim Labs' Gains from Investment Securities plummeted by 18076.92% in 2020 and then surged by 122500.0% in 2021.
  • Over the past 5 years, VivoSim Labs' Gains from Investment Securities (Quarter) stood at $26000.0 in 2019, then crashed by 180.77% to -$21000.0 in 2020, then surged by 104.76% to $1000.0 in 2021, then skyrocketed by 225400.0% to $2.3 million in 2022, then crashed by 100.4% to -$9000.0 in 2023.
  • Its Gains from Investment Securities was -$9000.0 in Q1 2023, compared to $2.3 million in Q1 2022 and $1000.0 in Q4 2021.